Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials.

Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of two single-institution prospective trials. J Immunother Cancer. 2020 Jan; 8(1).

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Immunological
Carcinoma, Non-Small-Cell Lung
Chemoradiotherapy
Clinical Trials as Topic
CTLA-4 Antigen
Female
Humans
Lung Neoplasms
Male
Middle Aged
Neoplasm Metastasis
Programmed Cell Death 1 Receptor
Prospective Studies
Radiosurgery
Retrospective Studies
Survival Rate
Treatment Outcome

authors with profiles

JAMES WELSH
MARIA ANGELICA ABDALLA CORTEZ